bf/NASDAQ:HLVX_icon.jpeg

COM:HILLEVAX

HilleVax, Inc.

  • Stock

Last Close

1.87

26/07 20:00

Market Cap

81.05M

Beta: -

Volume Today

602.78K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biopharmaceuticals
  • website

    hillevax.com
  • crunchbase

    hillevax
  • linkedin

    hillevax
  • founding date

    Jan 01, 2021
  • ipo date

    Apr 29, 2022

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

peer of